
Gynecology for Cancer Survivors & At-Risk Women
On this page
The UCSF Gynecology Center for Cancer Survivors and At-Risk Women offers innovative, compassionate gynecologic care for women who have completed cancer treatment or who are at high risk for developing cancer. We are a joint program of UCSF's women's health and cancer programs.
We address symptoms and issues such as:
- Chemotherapy-induced menopause
- Decisions about oophorectomy (ovary removal) for breast cancer patients and women at high risk for breast cancer
- Fertility preservation and reproductive concerns after breast cancer
- Hot flashes
- Low libido and sexual side effects
- Side effects of breast cancer drugs
- Sleep disturbances
- Vaginal dryness
In addition to caring for patients, we provide guidance to other gynecologists on managing uterine cancer risk and other side effects of hormonal therapies used to treat breast cancer.
The UCSF Gynecology Center for Cancer Survivors and At-Risk Women offers innovative, compassionate gynecologic care for women who have completed cancer treatment or who are at high risk for developing cancer. We are a joint program of UCSF's women's health and cancer programs.
We address symptoms and issues such as:
- Chemotherapy-induced menopause
- Decisions about oophorectomy (ovary removal) for breast cancer patients and women at high risk for breast cancer
- Fertility preservation and reproductive concerns after breast cancer
- Hot flashes
- Low libido and sexual side effects
- Side effects of breast cancer drugs
- Sleep disturbances
- Vaginal dryness
In addition to caring for patients, we provide guidance to other gynecologists on managing uterine cancer risk and other side effects of hormonal therapies used to treat breast cancer.
Providers

Mindy Goldman, MD
Obstetrics and Gynecology
Felicia C. Lester, MD, MPH
Obstetrics and Gynecology • Obstetrics and Gynecology (Complex Family Planning)
Tami Rowen, MD, MS
Obstetrics and Gynecology
Robin Litt, NP
Obstetrics and Gynecology
Related services
Related conditions & treatments
Conditions
- Infertility After Cancer Treatment
- Vasomotor Symptoms
- Cancer-Related Sexual Concerns
- Breast Cancer
- Gynecologic Cancer
Treatments
- Gynecologic Cancer Care
- Fertility Preservation
- Hormone Replacement Therapy
- Breast Cancer Follow-Up
Clinical trials
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerOpens in a new window
Recruiting
Objective response rate (ORR) is defined as the proportion of participants who experience complete response (CR) or partial response (PR) using Response Evalua...Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsOpens in a new window
Recruiting
Number of participants experiencing dose-limiting toxicities as defined in the protocol, including hematologic and non-hematologic toxicities, treatment-relate...Prospective Registry of ADC as First- and Second-line Treatment for Breast CancerOpens in a new window
Recruiting
rwPFS is defined as the amount of time that elapses between the initiation of ADC1 therapy until the patient experiences disease progression, initiates subsequ...A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerOpens in a new window
Recruiting
Severity of AEs determined according to the CTCAE v5.0 grading scale





